search
Back to results

Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery

Primary Purpose

Pain

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Magnesium metamizol
Placebo
Sponsored by
Boehringer Ingelheim
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain

Eligibility Criteria

6 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children of either sex between 6 and 11 years of age
  • Patients undergoing routine inguinal hernia repair or tonsillectomy
  • Written informed consents by the guardian, according to the guidelines of Good Clinical Practice and current legislation
  • The ability of the patient to understand and carry out the visual analogue scale assessments
  • Patients with a physical status American Society of Anesthesiologist I or II class

Exclusion Criteria:

  • The use of any drug with analgesic properties in the 24 hours prior to the administration of the study drug
  • Surgery with a foreseen duration over 60 minutes
  • Patients with a nutritional index of less than 90 or greater than 120
  • Patients with a body mass index which was not between the 3rd centile and the 97th centile for age
  • Patients with any illness or malformation (except hernia) which, in the doctor's opinion, contraindicated the use of metamizol (aplastic anemia, agranulocytosis of a toxicological etiology, severe renal disease, etc.)
  • Patients who have received in the previous 7 days or need currently anticoagulant treatment
  • Significant allergy or known hypersensitivity to metamizol, its excipients and/or to other nonsteroidal antiinflammatory drugs
  • Patients in whom the anesthetic regimen required by the protocol cannot be used
  • Patients who have participated in another clinical trial in the past four weeks or are currently participating in another clinical trial
  • Patients with any psychological disturbance which, in the investigator's opinion makes the patient unsuitable for inclusion in the trial

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Magnesium metamizol

    Placebo

    Arm Description

    Outcomes

    Primary Outcome Measures

    Percentage of children requiring rescue medication

    Secondary Outcome Measures

    Time from drug administration, end of surgery and first patient's awake to the administration of rescue medication
    Percentage of children who require rescue medication
    Evaluation of the pain intensity by the patient by means of a Visual Analogue Scale (VAS)
    Evaluation of the pain intensity by the patient by means of a four points Verbal Rating Scale (VRS)
    Assessment of the state of the patient by the guardian by means of the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) test
    Assessment of the partial efficacy by the investigator by means of a four points VRS
    Assessment of the total efficacy by the investigator by means of a four points VRS
    Number of patients with adverse events (AE)
    Number of withdrawals due to AEs
    Assessment of the total tolerability of the assigned treatment by the investigator by means of a four points VRS

    Full Information

    First Posted
    July 8, 2014
    Last Updated
    July 9, 2014
    Sponsor
    Boehringer Ingelheim
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02184273
    Brief Title
    Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery
    Official Title
    Randomized, Double Blind, Comparative Trial of the Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children of 6 and 11 Years Old Undergoing Minor Surgery
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2014
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2002 (undefined)
    Primary Completion Date
    March 2004 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Boehringer Ingelheim

    4. Oversight

    5. Study Description

    Brief Summary
    Study to assess the analgesic efficacy in the prevention of postoperative pain in children undergoing minor surgery (herniorraphy, tonsillectomy) and to assess the tolerability of Metamizol in this group of patients.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Double
    Allocation
    Randomized
    Enrollment
    122 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Magnesium metamizol
    Arm Type
    Experimental
    Arm Title
    Placebo
    Arm Type
    Placebo Comparator
    Intervention Type
    Drug
    Intervention Name(s)
    Magnesium metamizol
    Other Intervention Name(s)
    Nolotil
    Intervention Type
    Drug
    Intervention Name(s)
    Placebo
    Primary Outcome Measure Information:
    Title
    Percentage of children requiring rescue medication
    Time Frame
    up to 4 hours after drug administration
    Secondary Outcome Measure Information:
    Title
    Time from drug administration, end of surgery and first patient's awake to the administration of rescue medication
    Time Frame
    up to 4 hours
    Title
    Percentage of children who require rescue medication
    Time Frame
    up to 2 hours after drug administration
    Title
    Evaluation of the pain intensity by the patient by means of a Visual Analogue Scale (VAS)
    Time Frame
    up to 4 hours
    Title
    Evaluation of the pain intensity by the patient by means of a four points Verbal Rating Scale (VRS)
    Time Frame
    up to 4 hours
    Title
    Assessment of the state of the patient by the guardian by means of the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) test
    Time Frame
    up to 4 hours
    Title
    Assessment of the partial efficacy by the investigator by means of a four points VRS
    Time Frame
    up to 4 hours
    Title
    Assessment of the total efficacy by the investigator by means of a four points VRS
    Time Frame
    after 4 hours
    Title
    Number of patients with adverse events (AE)
    Time Frame
    up to 4 hours
    Title
    Number of withdrawals due to AEs
    Time Frame
    up to 4 hours
    Title
    Assessment of the total tolerability of the assigned treatment by the investigator by means of a four points VRS
    Time Frame
    after 4 hours

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Years
    Maximum Age & Unit of Time
    11 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Children of either sex between 6 and 11 years of age Patients undergoing routine inguinal hernia repair or tonsillectomy Written informed consents by the guardian, according to the guidelines of Good Clinical Practice and current legislation The ability of the patient to understand and carry out the visual analogue scale assessments Patients with a physical status American Society of Anesthesiologist I or II class Exclusion Criteria: The use of any drug with analgesic properties in the 24 hours prior to the administration of the study drug Surgery with a foreseen duration over 60 minutes Patients with a nutritional index of less than 90 or greater than 120 Patients with a body mass index which was not between the 3rd centile and the 97th centile for age Patients with any illness or malformation (except hernia) which, in the doctor's opinion, contraindicated the use of metamizol (aplastic anemia, agranulocytosis of a toxicological etiology, severe renal disease, etc.) Patients who have received in the previous 7 days or need currently anticoagulant treatment Significant allergy or known hypersensitivity to metamizol, its excipients and/or to other nonsteroidal antiinflammatory drugs Patients in whom the anesthetic regimen required by the protocol cannot be used Patients who have participated in another clinical trial in the past four weeks or are currently participating in another clinical trial Patients with any psychological disturbance which, in the investigator's opinion makes the patient unsuitable for inclusion in the trial

    12. IPD Sharing Statement

    Links:
    URL
    http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/1093/1093.18_U05-1666.pdf
    Description
    Related Info

    Learn more about this trial

    Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery

    We'll reach out to this number within 24 hrs